Morgan Stanley
BVS icon

Morgan Stanley’s Bioventus BVS Stock Holding History

Morgan Stanley’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Sell
193,734
-65,067
-25% -$621K ﹤0.01% 4899
2026
Q1 		$2.36M Sell
258,801
-43,457
-14% -$364K ﹤0.01% 4652
2025
Q4 		$2.25M Buy
302,258
+58,509
+24% +$421K ﹤0.01% 4729
2025
Q3 		$1.63M Sell
243,749
-409,162
-63% -$2.84M ﹤0.01% 4907
2025
Q2 		$4.32M Buy
652,911
+159,793
+32% +$1.13M ﹤0.01% 4172
2025
Q1 		$4.51M Sell
493,118
-149,484
-23% -$1.49M ﹤0.01% 4008
2024
Q4 		$6.75M Sell
642,602
-365,074
-36% -$4.32M ﹤0.01% 3732
2024
Q3 		$12M Buy
1,007,676
+484,235
+93% +$4.19M ﹤0.01% 3278
2024
Q2 		$3.01M Buy
523,441
+78,394
+18% +$430K ﹤0.01% 4286
2024
Q1 		$2.31M Buy
445,047
+251,518
+130% +$1.23M ﹤0.01% 4487
2023
Q4 		$1.02M Buy
193,529
+182,875
+1,716% +$724K ﹤0.01% 4913
2023
Q3 		$35.2K Sell
10,654
-8,061
-43% -$28.3K ﹤0.01% 6306
2023
Q2 		$54.1K Sell
18,715
-51,248
-73% -$98.4K ﹤0.01% 6180
2023
Q1 		$74.9K Sell
69,963
-47,129
-40% -$90.2K ﹤0.01% 6123
2022
Q4 		$306K Buy
117,092
+78,448
+203% +$343K ﹤0.01% 5481
2022
Q3 		$272K Buy
38,644
+28
+0.1% +$219 ﹤0.01% 5578
2022
Q2 		$262K Buy
38,616
+7,235
+23% +$73.8K ﹤0.01% 5761
2022
Q1 		$443K Sell
31,381
-27,039
-46% -$362K ﹤0.01% 5482
2021
Q4 		$847K Buy
58,420
+52,170
+835% +$742K ﹤0.01% 5191
2021
Q3 		$88K Sell
6,250
-12,171
-66% -$187K ﹤0.01% 6442
2021
Q2 		$324K Buy
18,421
+17,766
+2,712% +$286K ﹤0.01% 5764
2021
Q1 		$10K Buy
+655
New +$9.33K ﹤0.01% 6929

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley's BVS Position: Q2 2026 in Review

Morgan Stanley reduced its Bioventus (BVS) stake by 25% in Q2 2026, selling an estimated $621K and leaving 193,734 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #4899.

Morgan Stanley first reported a position in BVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $12M in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Morgan Stanley held 193,734 shares of Bioventus worth $1.83M as of Q2 2026.
  • Morgan Stanley sold 65,067 Bioventus shares in Q2 2026, an estimated $621K.
  • Bioventus made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4899 holding.
  • Morgan Stanley first reported a position in Bioventus in Q1 2021 and has held it in 22 quarters since.
  • Morgan Stanley's Bioventus position peaked at $12M in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.